
    
      Patients will be randomly assigned into two arms:

      Arm A : 68Ga-NODAGA-LM3 and 68Ga-DOTA-LM3 Arm B : 68Ga-NODAGA-LM3 and 68Ga-NODAGA-JR11

      In each arm, patients will undergo PET/CT using assigned tracers. Lesion detection, lesion
      SUV, and the tumor-to-background ratio will be compared.
    
  